Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Neurobiol Aging. 2010 Aug;31(8):1401–1418. doi: 10.1016/j.neurobiolaging.2010.04.029

Table 1.

Demographic Information and Neuropsychological Test Scores (Mean (SE))

AD
(n=152)
MCI-C
(n=60)
MCI-S
(n=261)
HC
(n=200)
p-value Significant Pair
Comparisons (p<0.05)
Baseline Age 75.33 (0.5) 74.04 (0.9) 75.07 (0.4) 75.95 (0.5) NS none
12mo Age 76.41 (0.5) 75.11 (0.9) 76.15 (0.4) 77.04 (0.5) NS none
Education 14.82 (0.2) 15.15 (0.4) 15.89 (0.2) 16.08 (0.2) p<0.001 HC, MCI-S>AD
Gender (M, F) 80, 72 35, 25 166, 95 105, 95 p=0.06 MCI-S vs. AD, HC
Handedness (R, L) 144, 8 55, 5 239, 22 185, 15 NS none
ApoE Genotype (% ApoE4+) 65.13% 58.33% 54.79% 28.00% p<0.001 AD, MCI-C, MCI-S>HC
Baseline CDR-SoB 4.18 (0.1) 2.00 (0.1) 1.52 (0.1) 0.02 (0.1) p<0.001 AD>MCI-C>MCI-S>HC
12mo Change in CDR-SoBa +2.13 (0.1) +2.64 (0.2) +1.26 (0.1) +1.1 (0.1) p<0.001 AD, MCI-C>MCI-S, HC
Baseline MMSE 23.53 (0.1) 26.58 (0.2) 27.11 (0.1) 29.11 (0.1) p<0.001 HC>MCI-S, MCI-C >AD
12mo Change in MMSEb −1.88 (0.7) −2.56 (0.4) −0.35 (0.2) 0.00 (0.2) p<0.001 HC, MCI-S>MCI-C, AD
Baseline RAVLTc 23.25 (0.7) 26.20 (1.1) 32.00 (0.5) 43.65 (0.6) p<0.001 HC>MCI-S>MCI-C, AD
12mo Change in RAVLTd −2.91 (0.5) −2.68 (0.8) −0.81 (0.4) +0.3 (0.5) p<0.001 HC>MCI-C, AD; MCI-S>AD
Baseline ICV 1552677.32
(13807.5)
1566297.83
(21976.7)
1570616.06
(10537.0)
1534944.90
(12037.1)
NS none
a

7 participants missing data (2 AD, 1 MCI-S, 4 HC)

b

2 participants missing data (1 MCI-S, 1 HC)

c

3 participants missing data (1 AD, 2 HC)

d

14 participants missing data (8 AD, 3 MCI-S, 3 HC)

HHS Vulnerability Disclosure